The services provided by Novozymes Biopharma AB are of great value to any pharmaceutical, biotechnology or veterinary medicine company aiming to use modern microbial fermentation technology. We are prepared to take an active part at any stage during the development of your biopharmaceutical inventions. We can bring your ideas closer to realization and have the qualifications to remain your partner after commercialization as well. This reduces the time to market and the risks inherent in any project of this kind, while minimizing costs and maximizing overall revenue.
Novozymes Biopharma AB is focused on the manufacturing process, including cell banking, process development, up-scaling and process validation. The range of services provides our customers with a one-stop-shop when it comes to the production of biological API (active pharmaceutical ingredients).
Characteristics of Novozymes Biopharma AB's cGMP production:
-
cGMP operations for biological API
-
Integrated process development, up-scaling and manufacturing
-
Supply of material for clinical studies as well as commercial use
-
Process development and design, including microbial fermentation, recovery and purification
-
Fed-batch and batch fermentations from 7 litres to 2 000 litres.
-
Excellent track record in cGMP manufacturing.